Microemulsion systems: Application in delivery of poorly soluble drugs

Colloids in Drug Delivery

Volumn , Issue , 2016, Pages 245-270

  Djekic, Ljiljana ^a   Primorac, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

MICROEMULSIONS;

MICROEMULSION SYSTEMS; POORLY SOLUBLE DRUGS;

DRUG DELIVERY;

EID: 85051151696     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Agatonovic-Kustrin, S. and Beresford, R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J. Pharm. Biomed. Anal. 2000; 22: 717-727.
2. Agatonovic-Kustrin, S., Glass, B. D., Wisch, M. H., and Alany, R. G. Prediction of stable microemulsion formulation for the oral delivery of a combination of antitubercular drugs using ANN methodology. Pharm. Res 2003; 20: 1760-1764.
3. Alany, R. G., Agatonovic-Kustrin, S., Rades, T., and Tucker, I. G. Use of artificial neural networks to predict quaternary phase systems from limited experimental data. J. Pharm. Biomed. Anal. 1999; 19: 443-452.
4. Amantea, J., Meier-Kriesche, H. U., Schoenberg, L., and Kahan, B. D. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporine used de novo after renal transplantation. Transplant Int. 1997; 10: 217-222.
5. Amidon, G. L., Lennernas, H., Shah, V. P., and Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995; 12: 413-420.
6. Andrysek, T. Impact of physical properties of formulations on bioavailability of active substance: Current and novel drugs with cyclosporine. Mol. Immunol. 2003; 39: 1061-1065.
7. Attama, A. A. and Nkemnele, M. O. In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int. J. Pharm. 2005; 304: 4-10.
8. Bagwe, R. P., Kanicky, J. R., Palla, B. J., Patanjali, P. K., and Shah, D. O. Improved drug delivery using microemulsions:Rationale, recent progress, and new horizons. Crit. Rev. Ther. Drug Carrier Syst. 2001; 18:77-140.
9. Borhade, V., Nair, H., and Hegde, D. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech 2008; 9: 13-21.
10. Chai, J.-L., Li, G.-Z., Zhang, G.-Y., Lu, J.-J., and Wang, Z.-N. Studies on the phase behavior of the system APG/alcohol/alkane/H2O with fishlike diagrams. Colloids Surf. A: Physicochem. Eng. Aspects 2003; 231: 173-180.
11. Chen, M.-L. Lipid excipients and delivery systems for pharmaceutical development-An FDA perspective. AAPS Workshop on the Effective Utilization of Lipid-Based Systems to Enhance the Delivery of Poorly Soluble Drugs, March 5-6, 2007, Bethesda, MD.
12. Cirri, M., Mura, P., and Mora, C. P. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int. J. Pharm. 2007; 340: 84-91.
13. Clausse, M., Nicolas Morgantini, L., Zradba, A., and Touraud, D. Water/ionic surfactant/alkanol/hydrocarbon system: Influence of certain constitution and composition parameters upon realms of existence and transport properties of microemulsion type media. In: HL Rosano and M Clausse (Eds.), Microemulsion Systems, pp. 15-63. New York: Marcel Dekker, 1987.
14. Constantinides, P. P. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm. Res. 1985; 12: 161-172.
15. Constantinides, P. P and Scalart, J. P. Formulation and physical characterisation of water-in-oil microemulsions containing long versus medium chain length glycerides. Int. J. Pharm. 1997; 158: 57-68.
16. Danielsson, I. and Lindman, B. The definition of a microemulsion. Colloids Surf. 1981; 3: 391-392.
17. Das, N. G. and Das, S. K. Formulation of poorly soluble drugs. Drug Deliv. Rep. 2006; Spring/Summer: 52-55.
18. Datea, A. A. and Patravale, V. B. Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interface Sci. 2004; 9: 222-235.
19. Debuigne, F., Cuisenaire, J., Jeunieau, L., Masereel, B., and Nagy, J. B. Synthesis of nimesulide nanoparticles in the microemulsion epikuron/isopropyl myristate/water/n-butanol or isopropanol. J. Colloid Interface Sci. 2001; 243: 90-101.
20. Djekic, L., Ibric, S., and Primorac, M. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems. Int. J. Pharm. 2008; 361:41-46.
21. Djekic, L. and Primorac, M. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. Int. J. Pharm. 2008; 352: 231-239.
22. Djordjevic, L. J, Primorac, M., and Stupar, M. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions. Int. J. Pharm. 2005; 296: 73-79.
23. Djordjevic, L. J., Primorac, M., Stupar, M., and Krajisnik, D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm. 2004; 271: 11-19.
24. Dunn, C. J., Wagstaff, A. J., Perry, C. M., Plosker, G. L., and Goa, K. L. Cyclosporin: An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral) in organ transplantation. Drugs 2001; 61: 1957-2016.
25. Erkko, P., Granlund, H., Nuutinen, M., and Reitamo, S. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Brit. J. Dermatol. 1997; 136: 82-88.
26. Evans, D. F. and Wennerstrom, H. The Colloidal Domain: Where Chemistry, Physics, Biology and Technology Meet. New York: VCH, 1994.
27. Ezrahi, S., Aserin, A. and Garti, N. Aggregation behaviour in one-phase (Winsor IV) microemulsion systems. In: P. Kumar and K.L. Mittal (Eds.), Handbook of Microemulsions: Science and Technology, pp. 185-246. New York: Marcel Dekker, 1999.
28. Fanun, M. and Al-Diyn, W. S. Electrical conductivity and self diffusion-NMR studies of the system: Water/ sucrose laurate/ethoxylated mono-di-glyceride/isopropylmyristate. Colloids Surf. A: Physicochem. Eng.Aspects 2006; 277: 83-89.
29. Fatouros, D. G., Karpf, D. M., Nielsen, F. S., and Mullertz, A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther. Clin. Risk Manage. 2007; 3: 591-604.
30. Fatouros, D. G., Nielsen, F. S., Douroumis, D., Hadjileontiadis, L. J., and Mullertz, A. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks. Eur. J. Pharm. Biopharm. 2008; 69: 887-898.
31. Fujii, M., Shiozawa, K., Henmi, T., Yamanouchi, S., Suzuki, H., Yamashita, N., and Matsumoto, M. Skin permeation of indomethacin from gel formed by fatty-acid ester and phospholipid. Int. J. Pharm. 1996; 137: 117-124.
32. Gasco, M. R. Method for producing solid lipid microspheres having a narrow size distribution. U.S. Patent 5250236, 1993.
33. Gasco, M. R. and Trotta, M. Nanoparticles from microemulsions. Int. J. Pharm. 1986; 29: 267-268.
34. Garti, N., Aserin, A., Spernath, A., and Amar, I. U.S. Patent Application 2003232095 A1 20031218, 2003.
35. Garti, N., Avrahami, M., and Aserin, A. Improved solubilization of celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J. Colloid Interface Sci. 2006; 299: 352-365.
36. Garti, N., Clement, V., Leser, M. Aserin, A., and Fanun, M. Sucrose ester microemulsions. J. Mol. Liq. 1999; 80: 253-296.
37. Gibson, L. Lipid-based excipients for oral drug delivery. In: D. J. Hauss (Ed.), Oral Lipid-Based Formulations:Enhancing the Bioavailability of Poorly Water-Soluble Drugs, pp. 43-51. New York: Informa Healthcare, 2007.
38. Glatter, O., Orthaber, D., Stradner, A., Scherf, G., Fanun, M., Garti, N., Clement, V., and Leser, M. E. Sugarester nonionic microemulsion: Structural characterization. J. Colloid Interface Sci. 2001; 241: 215-225.
39. Goddeeris, C., Coacci, J., and Van den Mooter, G. Correlation between digestion of the lipid phase of SMEDDS and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from SMEDDS. Eur. J. Pharm. Biopharm. 2007; 66: 173-181.
40. Goddeeris, C. and Van den Mooter, G. Free flowing solid dispersions of the anti-HIV drug UC 781 with poloxamer 407 and a maximum amount of TPGS 1000: Investigating the relationship between physicochemical characteristics and dissolution behaviour. Eur. J. Pharm. Sci. 2008; 35: 104-113.
41. Graf, A., Ablinger, E., Peters, S., Zimmer, A., Hook, S., and Rades, T. Microemulsions containing lecithin and sugar-based surfactants: Nanoparticle templates for delivery of proteins and peptides. Int. J. Pharm. 2008; 350: 351-360.
42. Grove, M., Mullertz, A., Nielsen, J. L., and Pedersen, G. P. Bioavailability of seocalcitol: II: Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur. J. Pharm. Sci. 2006; 28: 233-242.
43. Grove, M., Mullertz, A., Pedersen, G. P., and Nielsen, J. L. Bioavailability of seocalcitol: III. Administration of lipid-based formulations to minipigs in the fasted and fed state. Eur. J. Pharm. Sci. 2007; 31: 8-15.
44. Gupta, S. and Moulik, S. P. Biocompatible microemulsions and their prospective uses in drug delivery. J. Pharm. Sci. 2008; 97: 22-45.
45. Gursoy, R. N. and Benita, S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 2004; 58: 173-182.
46. Hauss, D. J. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 2007; 59: 667-676.
47. Heydenreich, A. V., Westmeier, R., Pedersen, N., Poulsen, H. S., and Kristensen, H. G. Preparation and purification of cationic solid lipid nanospheres-Effects on particle size, physical stability and cell toxicity. Int. J. Pharm. 2003; 254: 83-87.
48. Hoar, T. P. and Schulman, J. H. Transparent water-in-oil dispersions: The oleopathic hydro-micelle. Nature 1943; 152: 102-103.
49. Holm, R., Porter, C. J. H., Edwards, G. A., Mullertz, A., Kristensen, H. G., and Charman, W. N. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm. Sci. 2003; 20: 91-97.
50. Holt, D. W., Mueller, E. A., Kovarik, J. M., van Bree, J. B., and Kutz, K. The pharmacokinetics of Sandimmune Neoral: A new oral formulation of cyclosporine. Transplant. Proc. 1994; 26: 2935-2939.
51. Humberstone, A. J. and Charman, W. N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 1997; 25: 103-128.
52. Jannin, V., Musakhanian J., and Marchaud, D. Approaches for the development of solid and semi-solid lipidbased formulations. Adv. Drug Deliv. Rev. 2008; 60: 734-746.
53. Jing, Q., Shen, Y., Ren, F., Chen, J., Jiang, Z., Peng, B., Leng, Y., and Dong, J. HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits. J. Pharm. Biomed. Anal. 2006; 42: 613-617.
54. Kahlweit, M. Microemulsions. Annu. Rep. Prog. Chem. Sect. C 1999; 95: 89-115.
55. Kang, B. K., Lee, J. S., Chon, S. K., Jeong, S. Y., Yuk, S. H., Khang, G., Lee, H. B., and Cho, S. H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 2004; 274: 65-73.
56. Kang, B. K., Yoon, B. Y., Seo, K. S., Jeung, S. Y., Kil, H. J., Khang, G., Lee, H. B., and Cho, S. H. Preparation of solid dosage form containing SMEDDS of simvastatin by microencapsulation. J. Kor. Pharm. Sci. 2003; 33: 121-127.
57. Kemken, J., Ziegler, A., and Muller, B. W. Investigations into the pharmacodynamic effects of dermally administered microemulsions containing β-blockers. J. Pharm. Pharmacol. 1991; 43: 679-684.
58. Kemken, J., Ziegler, A., and Muller, B. W. Influence of supersaturation on the pharmacodynamic effect of bupranol after dermal administration using microemulsions as a vehicle. Pharm. Res. 1992; 9:554-558.
59. Khoo, S.-M., Humberstone, A. J., Porter, C. J. H., Edwards, G. A., and Charman, W. N. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 1998; 167: 155-164.
60. Khoo, S.-M., Shackeleford, D., Porter, C. J. H., Edwards, G. A., and Charman, W. N. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit dose lipid-based formulation to fasted dogs. Pharm. Res. 2003; 20: 1460-1465.
61. Klyashchitsky, B. A. and Owen, A. J. Drug delivery systems for cyclosporine: Achievements and complications. J. Drug Target. 1998; 5: 443-458.
62. Kogan, A. and Garti, N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci.2006; 123-126: 369-385.
63. Kommuru, T. R., Gurley, B., Khan, M. A., and Reddy, I. K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int. J. Pharm. 2001; 212:233-246.
64. Koynova, R. and Caffrey, M. An index of lipid phase diagrams. Chem. Phys. Lipids 2002; 115: 107-219.
65. Kovarik, J. M., Mueller, E. A., and Niese, D. Clinical development of a cyclosporin microemulsion in transplantation. Ther. Drug Monit. 1996; 18: 429-434.
66. Kovarik, J. M., Mueller, E. A., van Bree, J. B., Tetzloff, W., and Kutz, K. Reduced inter and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J. Pharm. Sci. 1994; 83:444-446.
67. Koziara, J. M., Whisman, T. R., Tseng, M. T., and Mumper, R. J. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J. Control. Release 2006; 112: 312-319.
68. Lawrence, M. J. and Rees, G. D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv.Rev. 2000; 45: 89-121.
69. Lee, J. M., Park, K. M., Lim, S. J., Lee, M. K., and Kim, C. K. Microemulsion formulation of clonixic acid:Solubility enhancement and pain reduction. J. Pharm. Pharmacol. 2002; 54: 43-49.
70. Li, P., Ghosh, A., Wagner, R. F., Krill, S., Joshi, Y. M., and Serajuddin, A. T. M. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 2005; 288: 27-34.
71. Ljusberg-Wahren, H., Nielsen, F. S., Brogard, M., Troedsson, E., and Mullertz, A. Enzymatic characterization of lipid-based drug delivery systems. Int. J. Pharm. 2005; 298: 328-332.
72. Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., and Allen, D. D. Brain uptake of thiamine-coated nanoparticles. J. Control. Release 2003; 93: 271-282.
73. Lopez-Quintela, M. A., Tojo, C., Blanco, M. C., Garcia Rio, L., and Leis, J. R. Microemulsion dynamics and reactions in microemulsions. Curr. Opin. Colloid Interface Sci. 2004; 9: 264-728.
74. Lu, J.-L., Wang, J.-C., Zhao, S.-X., Liu, X.-Y., Zhao, H., Zhang, X., Zhou, S.-F., and Zhang, Q. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur. J. Pharm. Biopharm. 2008; 69: 899-907.
75. Malmstein, M. Microemulsion in pharmaceuticals. In: P. Kumar and K.L. Mittal (Eds.), Handbook of Microemulsion: Science and Technology, pp. 755-772. New York: Marcel Dekker, 1999.
76. Mandawgade, S. D., Sharma, S., Pathak, S., and Patravale, V. B. Development of SMEDDS using natural lipophile:Application to β-artemether delivery. Int. J. Pharm. 2008; 362: 179-183.
77. Marchaud, D. and Hughes, S. Solid dosage forms from self-emulsifying lipidic formulations. Pharmaceutical Technology Europe, April 1, 2008.
78. Marengo, E., Cavalli, R., Caputo, O., Rodriguez, L., and Gasco, M. R. Scale-up of the preparation process of solid lipid nanospheres. Part II. Int. J. Pharm. 2000; 205: 3-13.
79. Mendyk, A. and Jachowicz, R. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst. Appl. 2007; 32: 1124-1131.
80. Mueller, E. A., Kovarik, J. M., van Bree, J. B., Tetzloff, W., Grevel, J., and Kutz, K. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm. Res. 1994; 11: 301-304.
81. Muller, R. H., Mader, K., and Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art. Eur. J. Pharm. Biopharm. 2000; 50: 161-177.
82. Narang, A. S., Delmarre, D., and Gao, D. Stable drug encapsulation in micelles and microemulsions. Int. J. Pharm. 2007; 345: 9-25.
83. Noble, S. and Markham, A. Cyclosporin: A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (NeoralR). Drugs 1995; 50: 924-941.
84. O'Driscoll, C. M. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 2002; 15:405-415.
85. Oyewumi, M. O., Yokel, R. A., Jay, M., Coakley, T., and Mumper, R. J. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J. Control. Release 2004; 95: 613-626.
86. Park, K. M., Lee, M. K., Hwang, K. J., and Kim, C. K. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm. 1999; 183: 145-154.
87. Patel, A. R. and Vavia, P. R. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007; 9(3): Article 41. http://www.aapsj.org
88. Patel, D. and Sawant, K. K. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev. Ind. Pharm. 2007; 33: 1318-1326.
89. Pitaksuteepong, T., Davies, N. M., Tucker, I. G., and Rades, T. Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsions. Eur. J. Pharm. Biopharm. 2002; 53: 335-342.
90. Pollard, S., Nashan, B., Johnston, A., Hoyer, P., Belitsky, P., Keown, P., and Helderman, H. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Clin. Ther. 2003; 25: 1654-1669.
91. Porter, C. J. H., Pouton, C. W., Cuine, J. F., and Charman, W. N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008; 60: 673-691.
92. Porter, C. J. H., Trevaskis, N. L., and Charman, W. N. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 2007; 6: 231-248.
93. Pouton, C. W. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 1997; 25: 47-58.
94. Pouton, C. W. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and "self-microemulsifying" drug delivery systems. Eur. J. Pharm. Sci. 2000; 11: S93-S98.
95. Pouton, C. W. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006; 29: 278-287.
96. Pouton, C. W. and Porter, C. J. H. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv. Drug Deliv. Rev. 2008; 60: 625-637.
97. Rane, S. S. and Anderson, B. D. What determines drug solubility in lipid vehicles: Is it predictable? Adv. Drug Deliv. Rev. 2008; 60: 638-656.
98. Reis, C. P., Neufeld, R. J., Ribeiro, A. J., and Veiga, F. Nanoencapsulation I. Methods for preparation of drugloaded polymeric nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2006; 2: 8-21.
99. Richardson, C. J., Mbanefo, A., Aboofazeli, R., Lawrence, M. J., and Barlow, D. J. Prediction of phase behavior in microemulsion systems using artificial neural networks. J. Colloid Interface Sci. 1997; 187:296-303.
100. Ritschel, W. A. Microemulsion technology in the reformulation of cyclosporine: The reason behind the pharmacokinetic properties of Neoral. Clin. Transplant. 1996; 10: 364-373.
101. Rowe, R. C., Sheskey, P. J., and Weller, P. J. (Eds.), Handbook of Pharmaceutical Excipients, 4th ed., pp. 454-459. London: Pharmaceutical Press/Washington, DC: American Pharmaceutical Association, 2003.
102. Sahiner, N., Alb, A. M., Graves, R., Mandal, T., McPherson, G. L., Reed, W. F., and John, V. T. Core-shell nanohydrogel structures as tunable delivery systems. Polymer 2007; 48: 704-711.
103. Schulman, J. H., Stoeckenius, W., and Prince, L. M. Mechanism of formation and structure of microemulsions by electron microscopy. J. Phys. Chem. 1959; 63: 1677-1680.
104. Sha, X., Yan, G., Wu, Y., Li, J., and Fang, X. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Cac o-2 cells. Eur. J. Pharm. Sci. 2005; 24: 477-486.
105. Shah, N. H., Carvajal, M. T., Patel, C. I., Infeld, M. H., and Malick, A. W. Self-emulsifying drug delivery systems with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 1994; 106: 15-23.
106. Shukla, A., Krause, A., and Neubert, R. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV. Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering. J. Pharm. Pharmacol. 2003; 55: 741-748.
107. Singh, A. K., Chaurasiya, A., Singh, M., Upadhyay, S. C., Mukherjee, R., and Khar, R. K. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): Development and optimization. AAPS PharmSciTech 2008; 9: 628-634.
108. Sjoblom, J., Lindbergh, R., and Friberg, S. E. Microemulsions-Phase equilibria characterization, structures, applications and chemical reactions. Adv. Colloid Interface Sci. 1996; 95: 125-287.
109. Soderlind, E., Wollbratt, M., and von Corswant, C. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int. J. Pharm. 2003; 252: 61-71.
110. Spernath, A. and Aserin, A. Microemulsions as carriers for drugs and nutraceuticals. Adv. Colloid Interface Sci.2006; 128-130: 47-64.
111. Strey, R. Microemulsion microstructure and interfacial curvature. Colloid Polym. Sci. 1994; 272: 1005-1019.
112. Strickley, R. G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004; 21: 201-230.
113. Subramanian, N., Ray, S., Ghosal, S. K., Bhadra, R., and Moulik, S. P. Formulation design of selfmicroemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull. 2004; 27:1993-1999.
114. Syamasri, G. and Moulik, S. P. Biocompatible microemulsions and their prospective uses in drug delivery. J. Pharm. Sci. 2008; 97: 22-45.
115. Taha, E. I., Al-Saidan, S., Samy, A. M., and Khan, M. A. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-transretinol acetate. Int. J. Pharm. 2004; 285:109-119.
116. Tarr, B. D. and Yalkowsky, S. H. Enhanced intestinal absorption of cyclosporin in rats through the reduction of emulsion droplet size. Pharm. Res. 1989; 6: 40-43.
117. Trotta, M., Gallarate, M., Carlotti, M. E., and Morel, S. Preparation of griseofulvin nanoparticles from waterdilutable microemulsions. Int. J. Pharm. 2003; 254: 235-242.
118. Ugazio, E., Cavalli, R., and Gasco, M. R. Incorporation of cyclosporin A in solid lipid nanoparticles. Int. J. Pharm. 2002; 241: 341-344.
119. Vandamme, Th. F. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog. Retin. Eye Res. 2002; 21: 15-34.
120. von Corswant, C., Thoren, P., and Engstrom, S. Triglyceride-based microemulsion from intravenous administration of sparingly soluble substances. J. Pharm. Sci. 1998; 87: 200-208.
121. Vonderscher, J. and Meinzer, A. Rationale for the development of Sandimmune Neoral. Transplant. Proc. 1994; 26: 2925-2927.
122. Watnasirichaikul, S., Davies, N. M, Rades, T., and Tucker, I. G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res. 2000; 17: 684-689.
123. Watnasirichaikul, S., Rades, T., Tucker, I. G., and Davies, N. M. Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 2002; 235: 237-246.
124. Wei, L., Sun, P., Nie, S., and Pan, W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev. Ind. Pharm. 2005; 31: 785-794.
125. Wennerstrom, H., Balogh, J., and Olsson, U. Interfacial tensions in microemulsions. Colloids Surf. A:Physicochem. Eng. Aspects 2006; 291: 69-77.
126. Woo, J. S., Song, Y.-K., Hong, J.-Y., Lim, S.-J., and Kim, C.-K. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur. J. Pharm. Sci. 2008; 33: 159-165.
127. Wu, W., Wang, Y., and Que, L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 2006; 3: 288-294.
128. Yi, T., Wan, J., Xu, H., and Yang, X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 2008; 70:439-444.
129. Ying, C., Gao, L., Xianggen, W., Zhiyu, C., Jiangeng, H., Bei, Q., Song, C., and Ruihua, W. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: Formulation development and in vivo assessment. Biol. Pharm. Bull. 2008; 31: 118-125.
130. Zhang, P., Liu, Y., Feng, N., and Xu, J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 2008; 355: 269-276.
131. Zhengrong, C. and Mumper, R. J. Topical immunization using nanoengineered genetic vaccines. J. Control. Release 2002; 81: 173-84.